Latest Breaking News On - பல்கலைக்கழகம் ஆஃப் மேரிலாந்து இல் பால்டிமோர் - Page 7 : comparemela.com

Published: Feb 23, 2021     PHILADELPHIA (BUSINESS WIRE) Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that Adam Dinerman, Ph.D. and John Liu, Ph.D. have joined the company as Executive Director, Head of Chemistry, Manufacturing and Controls (CMC) and Vice President, Biology, respectively. “The addition of top talent with deep functional experience is a critical success driver for Aro as we enter our next phase of growth,” stated Sue Dillon, Ph.D., co-founder and Chief Executive Officer of Aro Biotherapeutics. “We are very excited that Adam and John are joining our company, and are confident that they will both add tremendous value to our organization as our pipeline and platform continue to advance.”

United statesZhonghao john liuAdam dinermanJohn liuJohnson janssenUniversity of maryland at baltimoreWashington university school of medicineWashington university in stMetabolex incExecutive directorVice presidentSue dillonChief executive officerPharmaceutical sciencesDevelopmental biologyWashington university